Pacira BioSciences, Inc.: Providing Non-Opioid Pain Management and Regenerative Health Solutions Pacira BioSciences, Inc. is a company offering cutting-edge non-opioid pain management and regenerative health solutions for healthcare practitioners and their patients in the United States. The Florida-based company provides a range of products, including EXPAREL, a bupivacaine liposome injectable suspension; ZILRETTA, a triamcinolone acetonide extended-release injectable suspension; and iovera system, a non-opioid handheld cryoanalgesia device that offers controlled doses of cold temperature to targeted nerves. In addition to these groundbreaking products, Pacira BioSciences has also developed proprietary multivesicular liposome technology, which encapsulates drugs without altering their molecular structure, resulting in more efficient drug delivery. Formerly known as Pacira Pharmaceuticals, Inc., the company changed its name to Pacira BioSciences, Inc. in April 2019. Since its incorporation in 2006, Pacira BioSciences has been at the forefront of the non-opioid pain management and regenerative health solutions industry, providing innovative solutions to healthcare practitioners nationwide.
Pacira BioSciences Inc's ticker is PCRX
The company's shares trade on the NASDAQ stock exchange
They are based in Parsippany, New Jersey
There are 201-500 employees working at Pacira BioSciences Inc
It is pacira.com
Pacira BioSciences Inc is in the Healthcare sector
Pacira BioSciences Inc is in the Drugs - Generic industry
The following five companies are Pacira BioSciences Inc's industry peers: